The novel dual glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 (GLP-1) receptor agonist Tirzepatide transiently delays gastric emptying similarly to selective long-acting GLP-1 receptor agonists
Supports lean muscle mass, strength, recovery, and metabolic function during periods of reduced calorie intake
Gracias Mara Hola, Mara
PMID 25187433, retraction notice PMID 40312093), and a third (PMID 23055539) carries a 2021 Expression of Concern
There is less known about tirzepatide (Mounjaro, Zepbound) because it is a relatively member of this drug family
In addition, we have passed SEDEX audit, FDA, I S O 2 2 7 1 6 and GMPC, also our product passed REACH, TRA, SDS test report